Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1739_Библиотеки_им_академика_М_И_Перельмана.pdf
94
A Simple Introduction to Organ Transplant
Dr Gopi Ayyaswamy
of reactive oxygen species due to insufcient perfusion. The activation of
inammatory mediators plays a central role in the pathophysiological events
following brain death. Among these mediators are the complement system,
thromboxanes, platelet factors, and leukocyte factors.
Over time, a progressive inux of leukocytes occurs within solid organs,
accompanied by a continuous deterioration of the inammatory response.
This ongoing inammatory process enhances the immunogenicity of the
graft, thereby increasing the risk of rejection post-transplantation. Various
inammatory compounds show measurable increases during this period,
including intercellular adhesion molecule-1 (ICAM-1), vascular cellular
adhesion molecule-1, E-selectin, interleukin-6, interferon-G, macrophage
inammatory protein-1α, tumor necrosis factor, and numerous others.
These physiological changes exemplify the complex and multifaceted
nature of the body’s response to brain death. The depletion of energy
stores, calcium overload, endothelial swelling, reactive oxygen species
accumulation, and inammatory activation all contribute to the challenges
faced in the context of organ donation and transplantation.
Understanding these intricate processes is not only a matter of scientic
curiosity but also a crucial step in the quest to improve outcomes for organ
transplantation. It is through this understanding that medical professionals
can develop effective strategies to mitigate the adverse effects of brain
death on organ viability and function. By addressing these physiological
changes head-on, the medical community can work towards optimizing the
success of organ donation and ultimately offer a new lease of life to those
in need of life-saving transplants. Brain death sets in motion a series of
complex and interconnected physiological changes within the body. These
changes impact multiple organ systems and pose signicant challenges
in the context of organ donation and transplantation. Recognizing and
addressing these challenges is a fundamental step in ensuring the success
of organ transplantation and, ultimately, in saving lives through the gift
of organ donation.
Methodology in Maintenance
Implementing a comprehensive methodology is essential to ensure proper
maintenance in the context of organ donation. When faced with time
Complexities of Intensive Care
95
Dr Gopi Ayyaswamy
constraints, obtaining a thorough and detailed medical history becomes
even more critical. Open and honest discussions with the patient’s
family are vital, starting with a clear explanation of the patient’s critical
condition and the process of organ donation. To avoid any potential
misunderstandings later on, it may be helpful to dene relevant medical
terminology, such as circulatory arrest and brain death.
The next step in the methodology involves evaluating the patient’s
suitability as a donor. In most cases, if there is an overwhelming infectious
process or an active malignancy, organ donation would not be possible.
Therefore, it is crucial to rule out these diagnoses, along with other
pre-existing conditions that could impact the functional capacity of the
organs and hinder their usability. It is important to note that signicant
physiological changes, which can be detrimental, may start occurring
several hours before the diagnosis of brain death. The longer this process
persists, the higher the likelihood of complications arising, potentially
leading to the loss of any chance for organ recovery. During this phase,
the primary focus should be on providing supportive care to the dying
patient. However, preparations should also be made to transition from
cerebral protective measures to optimizing the functionality of the donor
organs immediately after brain death is pronounced.
Once the diagnosis of brain death is conrmed, it is crucial to ensure
that the family fully understands its irreversibility and that their loved one
is considered deceased. Providing the family with private time after the
pronouncement of brain death has been shown to increase the likelihood
of obtaining consent for organ donation. Moreover, it is advisable for the
request to be made by experienced personnel who can effectively address
any concerns raised by the family members. Successful identication
and conversion of a potential donor into an actual donation require
a coordinated team approach. While brain death has been dened in
various ways in the past, current guidelines and diagnostic criteria aim
to achieve an indisputable clinical diagnosis of the irreversible loss of all
brain functions. It is important to note that conrmatory studies, such
as a cerebral angiogram, are not obligatory. Despite improvements in
HLA matching, graft survival from brain-dead donors generally tends
to be inferior to that from living-unrelated donors due to the presence of
multiple physiological abnormalities.
Dr Gopi Ayyaswamy
Donor Management
13
The management of brain-dead donors has witnessed signicant progress,
departing from the conventional approach of passive waiting for the
organ retrieval team. Instead, the implementation of standardized and
systematic critical care therapy has demonstrated its ability to enhance
both the quantity and quality of transplanted organs.
Hypotension emerges as a prevalent occurrence in almost all brain-
dead patients, often stemming from multiple contributing factors. Among
these factors, hypovolemia plays a signicant role. Hypovolemia can arise
from various conditions, such as traumatic blood loss, which contributes
to reduced blood volume. Additionally, central diabetes insipidus,
characterized by excessive urination and extreme thirst, can also lead
to hypovolemia. Moreover, prior uid restriction and diuretic therapy,
administered to manage other medical conditions, can further exacerbate
hypovolemia in brain-dead donors.
To optimize donor management and counteract hypotension, it is
essential to address the underlying causes of hypovolemia. This may
involve the administration of intravenous uids to replenish blood volume
and maintain adequate blood pressure. Close monitoring of uid balance
and electrolyte levels assumes paramount importance in preventing
further complications and ensuring the stability of the donor’s condition.
Furthermore, comprehensive critical care therapy encompasses various
other crucial aspects that should not be overlooked in donor management.
Proper management of endocrine abnormalities, such as addressing
diabetes insipidus, is important to maintain uid balance and prevent
disruptions in the donor’s physiological equilibrium. Additionally,
98
A Simple Introduction to Organ Transplant
Dr Gopi Ayyaswamy
optimizing hemodynamics, addressing electrolyte imbalances, and
ensuring adequate organ perfusion are all vital components of effective
donor management.
By implementing standardized and systematic critical care therapy,
medical professionals adopt an active role in stabilizing and optimizing
the condition of brain-dead donors. This approach ensures that potential
organ donors receive appropriate medical interventions to preserve organ
function and improve the overall outcome of transplantation. The focus has
shifted from solely waiting for organ retrieval to proactive management
aimed at maximizing the number and viability of organs available for
transplantation. Through this comprehensive and proactive approach,
the medical community can make signicant strides in the eld of organ
transplantation, enhancing the chances of success and positively impacting
the lives of those in need of life-saving organs.
Clinical Criteria for Brain Death
Exclude
• Hypothermia (less than 32°C), neuromuscular blocking agents, central
nervous system depressants (intoxicant, poison, sedative, hypnotic,
narcotic, etc.)
• Central nervous system abnormalities (locked-in syndrome, Guillain-
Barré syndrome, encephalitis, etc.)
• Acute metabolic derangements (hepatic coma, uremic coma,
hypoglycemia, abnormal pH or electrolyte, etc.)
Examination
• Unresponsiveness, absence of cerebral and brainstem functions
• Absence of corneal reexes and pupillary response to light
• Absence of pharyngeal and tracheal reexes
• Absence of caloric response
• Absence of respiratory drive at a partial pressure of arterial carbon
dioxide that is 60 mm Hg, or 20 mm Hg above normal base-line values
• Interval between two evaluations (by patient’s age) for conrmation of
brain death
Donor Management
99
Dr Gopi Ayyaswamy
• Term to 2-month-old: 48 hours, 2 months to 1-year-old: 24 hours,
• 1 to 18 years old: 12 hours
• Above 18 years old: Interval is optional (As per THOA guidelines it is
6 hours)
Confirmatory Tests
• Term to 2-month-old: 2 conrmatory tests
• 2 months to 1-year-old: 1 conrmatory test
• Above 1-year-old conrmatory test is optional (in Indian context it is
6 hours)
Confirmatory Tests to Establish Brain Death
The accurate determination of brain death in potential organ donors
is primarily essential. To ensure the irreversible cessation of all brain
functions, a series of conrmatory tests are employed, each serving as a
vital component in establishing the diagnosis of brain death.
1. Electroencephalogram (EEG): Utilizing non-invasive techniques, an
EEG records the electrical activity within the brain. In cases of brain
death, the EEG presents a at or isoelectric pattern, signifying the
absence of any brain activity. This test serves as an important tool in
conrming the loss of neurological function.
2. Transcranial Doppler ultrasonogram: Employing ultrasound
technology, a transcranial Doppler ultrasonogram assesses blood ow
within the blood vessels of the brain. In instances of brain death, the
absence of detectable blood ow in the cerebral arteries reinforces the
diagnosis, solidifying the lack of brain function.
3. Spiral computer tomogram (CT) and magnetic resonance imaging
(MRI): Both CT and MRI scans offer detailed images of the brain,
enabling healthcare professionals to identify any structural abnormalities
or injuries that may have contributed to brain death. These imaging
modalities play a crucial role in ruling out potential reversible causes
of brain dysfunction.
4. Cerebral angiogram: A cerebral angiogram involves the injection of
a contrast dye into the blood vessels of the brain. By visualizing the
cerebral arteries, this test provides valuable information regarding blood
100
A Simple Introduction to Organ Transplant
Dr Gopi Ayyaswamy
ow within the brain. In cases of brain death, the angiogram exhibits a
lack of blood ow in the cerebral arteries, further validating the absence
of brain activity.
5. Technetium (Tc 99m) cerebral scintigram: Utilizing nuclear medicine
techniques, a Technetium cerebral scintigram involves the injection of
a radioactive tracer into the bloodstream to assess cerebral blood ow.
Like other conrmatory tests, it conrms the absence of blood ow
within the brain, reinforcing the diagnosis of brain death.
These confirmatory tests collectively form a comprehensive and
meticulous approach to establish brain death. By employing a combination
of neurophysiological, imaging, and nuclear medicine techniques,
medical professionals can condently conrm the irreversible loss of all
brain functions. This accurate determination of brain death ensures the
integrity and reliability of the organ donation process, ultimately saving
and improving the lives of organ transplant recipients (Source: MJAFI,
Vol. 65, No. 2, 2009).
Management Strategies for Donor Optimization
The loss of sympathetic tone in brain-dead donors exacerbates the challenges
faced during organ preservation and transplantation. Vasodilation,
blunted vasomotor reexes, and impaired cardiac contractility are some of
the complications that arise due to the absence of sympathetic control. To
address these issues, various cardiovascular support algorithms have been
developed with the aim of achieving better postoperative graft function
and optimizing organ preservation before organ recovery.
The initial focus in donor management revolves around restoring
euvolemia, which entails maintaining a normal blood volume. This step
is typically undertaken before initiating aggressive pharmacological
interventions. The choice between crystalloid and colloid uids remains
inconclusive in terms of their comparative benets. However, it is crucial
to maintain intravascular volume and colloid oncotic pressure within the
physiological range, while ensuring a hemoglobin concentration above
10 g/dl. These goals contribute to the overall therapeutic strategy.
Achieving a central venous pressure of 6–10 mm Hg may require
the administration of a combination of blood components, crystalloid
Donor Management
101
Dr Gopi Ayyaswamy
solutions, and albumin. However, caution must be exercised to avoid
using 31-hydroxyethyl starch due to its potential to cause renal tubular
injury and impaired postoperative renal graft function.
Optimizing oxygen delivery is a key objective in preventing metabolic
deterioration of donor organ function. Echocardiography and/or
pulmonary artery catheter monitoring are employed to assess preload,
cardiac output, and guide vasoactive therapy. Once cardiac lling is
restored, intravenous catecholamines are administered to enhance
contractility and vascular resistance. The goal is to maintain a cardiac index
above 2.4 liters/min/m
2
and a mean arterial blood pressure above 60 mm
Hg. While the use of catecholamines should be limited to avoid adverse
effects such as excessive vasoconstriction and depletion of myocardial
high-energy substrates, evidence supports the preference for dopamine as
the inotrope of choice at doses less than 10 µg/kg/min. Studies indicate
that norepinephrine administration is associated with an increased
incidence of cardiac graft failure, whereas dopamine, dobutamine, and
epinephrine do not have the same negative impact.
In addition to improving oxygen delivery, adrenergic drugs may
offer additional benets, such as scavenging oxygen radicals, inhibiting
inammatory mediators, and modifying leukocyte adhesion. Another
complication that can arise in brain-dead donors is diabetes insipidus,
resulting from pituitary infarction. This condition leads to excessive
urine production (polyuria) and electrolyte abnormalities, including
hypovolemia, hyperosmolarity, hypernatremia, and hypokalemia.
Pharmacological interventions, such as the use of desmopressin or
vasopressin, along with volume replacement, are necessary to correct
these electrolyte imbalances. The therapeutic target for desmopressin
or vasopressin therapy is to achieve an hourly urine output of 0.5 to
2 ml/kg.
Managing brain-dead donors necessitates a comprehensive approach
to optimize organ viability for transplantation. Restoring euvolemia,
optimizing oxygen delivery, and addressing complications such as
diabetes insipidus are crucial steps in this process. By implementing these
strategies, healthcare professionals can enhance the chances of successful
organ transplantation, ultimately saving more lives.
102
A Simple Introduction to Organ Transplant
Dr Gopi Ayyaswamy
Management Considerations in Brain-Dead Donors
Arrhythmias are a common occurrence in brain-dead donors, with varying
prevalence rates. These arrhythmias can be attributed to myocardial injury
resulting from the massive sympathetic surge during brain herniation, as
well as electrolyte imbalances. Tachycardia, often induced by exogenous
catecholamines, can be effectively managed by switching to different
vasopressors or administering intravenous blockers.
On the other hand, brady arrhythmias present a therapeutic challenge
in brain-dead patients. Since these patients lack vagal tone, traditional
anticholinergic drugs are ineffective in increasing heart rates. In cases
where strong chronotropic agents like isoproterenol fail to restore
heart rate, electrical pacing becomes necessary to prevent circulatory
compromise. Agonal arrhythmias, such as ventricular brillation and
asystole, are particularly resistant to therapeutic interventions. This further
underscores the importance of expediting organ retrieval to minimize the
risks associated with these arrhythmias.
Neurogenic pulmonary edema is a common pulmonary complication
observed in brain-dead donors. Optimal respiratory care involves avoiding
lung injury caused by suboptimal mechanical ventilation strategies and
preventing aspiration pneumonitis. Relative hypoxemia, indicated by a low
PaO
2
/FiO
2
ratio, can be caused by excessive uid resuscitation, but this can be
easily corrected. Judicious intravenous uid administration, corticosteroids,
diuretic therapy, and aggressive pulmonary toilet have all been shown to
improve lung procurement and increase the success of transplantation.
Therefore, a nal decision on the suitability of the donor’s lungs should
not be made before employing appropriate treatment options to optimize
gas exchange and pulmonary function. Additional diagnostic tools such
as chest radiographs and ber optic bronchoscopy can aid in the decision-
making process.
Hypothermia is a common occurrence in approximately half of all brain-
dead donors. It is primarily caused by the loss of hypothalamic temperature
regulation and generalized vasodilation. Prevention of heat loss through
the use of forced air blankets, heated mattresses, and administration of
warmed intravenous uids is more effective than attempting to restore
normothermia in a hypothermic donor.
Donor Management
103
Dr Gopi Ayyaswamy
Hyperglycemia in brain-dead donors is rarely indicative of pancreatic
insufciency. It is typically a result of peripheral insulin resistance. Prompt
correction of hyperglycemia is essential to avoid hyperosmolality, osmotic
diuresis, electrolyte abnormalities, and subsequent cardiac instability.
Coagulopathy is another common issue in brain-dead donors,
often attributed to thrombocytopenia, hypothermia, and the massive
release of plasminogen activators and other tissue compounds. Transfusion
of different blood components is frequently required to address this
coagulopathy. Accepted therapeutic endpoints include an international
normalized ratio below 2.0 and a platelet count over 50,000/mm
3
.
Endocrine deficiencies of varying degrees have been observed in
studies of brain-dead individuals. Autopsy ndings often reveal posterior
pituitary infarction and partial destruction of the anterior pituitary.
Hormone replacement therapy should be strongly considered to stabilize
the hemodynamically marginal donor.
The management of brain-dead donors involves addressing various
complications that arise in these individuals. Effective management of
arrhythmias, pulmonary complications, hypothermia, hyperglycemia,
coagulopathy, and endocrine deciencies can signicantly improve the
chances of successful organ transplantation. By implementing appropriate
therapeutic interventions, healthcare professionals can optimize donor
viability and enhance the outcomes of transplantation procedures.
Advancements in Donor Care for Organ Transplantation
The eld of organ transplantation has witnessed signicant advancements
in donor care, with the administration of various medications playing
a crucial role in improving outcomes. Studies in both animals and
humans have shown promising results with the use of thyroid hormone,
corticosteroids, vasopressin, and insulin. These medications, whether used
alone or in combination, have demonstrated their potential in enhancing
cardiac function, increasing the number of viable organs available for
transplantation, and improving graft survival.
Another area of focus in optimizing organ transplantation outcomes is
cytoprotective therapy. The goal of cytoprotective therapy is to reduce the
initial inammatory process in the donor, which can have a signicant impact